CytoDyn Inc. announced earnings results for the second quarter ended November 30, 2018. For the second quarter, the company announced operating loss was USD 15.687 million compared to USD 10.775 million a year ago. Net loss was USD 14.305 million compared to USD 10.947 million a year ago. Basic loss per share from continuing operations was USD 0.06 compared to USD 0.07 a year ago. For the half year, operating loss was USD 29.176 million compared to USD 20.582 million a year ago. Net loss was USD 28.718 million compared to USD 22.575 million a year ago. Basic loss per share from continuing operations was USD 0.12 compared to USD 0.15 a year ago.